Though guidelines suggest screening starts at 50, researcher says it's premature to change them
by yrles1 on Mon Feb 21, 2011 02:18 PM
Has anyone investigated BC-819 aka DTA-H19 as a treatment option for Pancreatic Cancer? I have studied the trials, and they have met with good success. It is my understanding BC-819 has been given Orphan drug status, and is already approved for compassionate use in other cancers.
A clinical trial request for the combo of BC-819/Gemzar will be requested. I have yet to find out when that will take place. I am interested in knowing the in's & out's of off label/and compassionate use for this product and have contacted the maker (Biocancell). Hoping for a response. They are working with The Massey Cancer Center, and the University of Maryland.
Any futher info would be greatly appreciated!
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
We care about your feedback. Let us know how we can improve your CancerCompass experience.